1 Vanguard ETF Up 23% in 12 Months (Hint: It's Not VOO). Here's What History Says Investors Should Do.

Vanguard Total International Stock ETF (VXUS) is up about 23% over the past 12 months (as of Aug. 18) and has outperformed the S&P 500 during that period, though the article frames this as potentially one-off rather than a durable trend. The piece highlights VXUS’s low expense ratio versus the broad U.S. concentration risk, noting the ETF holds key AI-exposure names like TSMC, Samsung, and ASML and is most represented by Japan. It suggests allocating 5%–10% of a portfolio to international equities for geographic diversification rather than expecting consistent outperformance.

Analysis

The real mechanism here is not “international is better,” it’s factor rotation: a modest reallocation away from crowded U.S. mega-cap indices can mechanically support VXUS through passive flows even if fundamentals abroad don’t improve much. But the benefit is uneven — the ETF’s marginal winners are its AI-adjacent heavyweight holdings (TSM, ASML, SSNLF), not the broad basket, so the trade is really a way to own semiconductor capex and non-U.S. balance-sheet exposure at a lower multiple than U.S. tech.

The main loser is U.S. market concentration, not the economy itself. If investors start trimming SPY/VOO or QQQ to fund geographic diversification, the first-order effect is multiple compression at the top of the U.S. index, but the second-order effect is narrower: high-duration U.S. growth names are most vulnerable because they depend on continued crowding and lower discount rates. That said, if the dollar remains firm and U.S. earnings revisions keep outpacing ex-U.S., VXUS can underperform for months despite appearing “cheap.”

Catalysts are mostly macro, not company-specific: DXY, tariff rhetoric, and any sign that U.S. fiscal deficits translate into a weaker dollar or higher term premium. Over 1-3 months, flows can help; over 6-18 months, the thesis only works if the dollar trend turns and global manufacturing cycles stabilize. The contrarian miss is that buying VXUS is often a disguised macro short on U.S. exceptionalism, not a pure diversification trade.

There may be no strong standalone alpha here unless we get a dollar inflection or evidence of sustained ETF reallocation into ex-U.S. assets. The cleaner expression is selective ownership of the top AI supply-chain beneficiaries, not the broad international ETF.

Key Decisions for Investors

• Avoid chasing VXUS after a strong relative run unless DXY breaks lower; treat it as a 6-18 month macro hedge, not a near-term momentum trade.
• If USD softness emerges, buy VXUS vs. short SPY/VOO as a low-conviction relative-value pair; the trade works best if U.S. mega-cap crowding starts to unwind.
• Prefer selective longs in TSM and ASML over broad VXUS if the goal is non-U.S. AI exposure; they capture the capex spend with better quality and clearer earnings sensitivity.
• Use QQQ as the funding leg for any ex-U.S. rotation trade; the risk/reward is tied to multiple compression in the most crowded U.S. duration assets, not to broad market beta.
• Set an alert for DXY and 10Y real yields: a sustained breakout higher in either would falsify the VXUS diversification thesis and argue for reducing exposure.